CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines

January 23, 2025 Latest News Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

Vaxxas CEO David Hoey said, “Our HD-MAP technology offers a potential solution to the growing need to significantly expand global access to innovative mRNA vaccines by eliminating the current ultra-cold storage requirements for these vaccines." …

Subscribe now to continue reading.

CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines

This is a preview of subscriber content

Latest Video

Most Read

Medicines Australia calls for transparency, highlighting the risk of bias

Time to make this 'targeted' consultation a little less targeted

Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer

Australia approves first in class therapy for chronic graft versus host disease

The review is formally over. Why is it restarting?

New Stories

Moderna expands support for early career Australian mRNA researchers

The review is formally over. Why is it restarting?

AI screening tool gives pathologists 'super' vision to detect hidden cancer

Australian company celebrated in centenary project on royal and parliamentary leadership

La Trobe launches REACH program to fight antimicrobial resistance

If the imperative is international comparison, why limit it to these definitions?

Therapy funded three years after the 'clunky' and 'preventable deaths' admission

Sign In

CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines

This is a preview of subscriber content

Latest Video

Most Read

Medicines Australia calls for transparency, highlighting the risk of bias

Time to make this 'targeted' consultation a little less targeted

Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer

Australia approves first in class therapy for chronic graft versus host disease

The review is formally over. Why is it restarting?

Follow Us

New Stories

Moderna expands support for early career Australian mRNA researchers

The review is formally over. Why is it restarting?

AI screening tool gives pathologists 'super' vision to detect hidden cancer

Australian company celebrated in centenary project on royal and parliamentary leadership

La Trobe launches REACH program to fight antimicrobial resistance

If the imperative is international comparison, why limit it to these definitions?

Therapy funded three years after the 'clunky' and 'preventable deaths' admission